Literature DB >> 1443892

Miliary Mycobacterium bovis induced by intravesical bacille Calmette-Guérin immunotherapy.

C McParland1, D J Cotton, K S Gowda, V H Hoeppner, W T Martin, P F Weckworth.   

Abstract

Intravesical instillation of bacille Calmette-Guérin (BCG), an attenuated strain of Mycobacterium bovis, is the treatment of choice for many patients with bladder cancer. In a small percentage, this therapy is associated with systemic side effects including pneumonitis. It is uncertain whether these systemic manifestations are due to dissemination of infection or due to hypersensitivity, an etiologic distinction that has important therapeutic implications. We report the first case in which miliary M. bovis was proven to be the responsible mechanism, by culture of M. bovis biovar BCG from a transbronchial lung biopsy and complete resolution on anti-tuberculous chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443892     DOI: 10.1164/ajrccm/146.5_Pt_1.1330

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  [Dyspnea after instillation therapy for bladder cancer].

Authors:  D Julius; H F Geerdes Fenge; M-A Weber
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

2.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

3.  Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

Authors:  F W Leebeek; R J Ouwendijk; A H Kolk; A Dees; J C Meek; J E Nienhuis; A M Dingemans-Dumas
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

4.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

Review 5.  The new diagnostic mycobacteriology laboratory.

Authors:  M Salfinger; G E Pfyffer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-11       Impact factor: 3.267

6.  Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high- performance liquid chromatography.

Authors:  Amr M Mohamed; Dhundy R Bastola; Glenn P Morlock; Robert C Cooksey; Steven H Hinrichs
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

7.  Acute renal failure due to interstitial nephritis after intravesical instillation of BCG.

Authors:  Maria Jose Manzanera Escribano; Enrique Morales Ruiz; Mónica Odriozola Grijalba; Eduardo Gutierrez Martínez; Alfredo Rodriguez Antolín; Manuel Praga Terente
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

8.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

9.  Disseminated infection due to Mycobacterium bovis after intravesical BCG instillation.

Authors:  Sara Marquez-Batalla; Esther Fraile-Villarejo; Moncef Belhassen-García; Nieves Gutierrez-Zubiaurre; Miguel Cordero-Sánchez
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

10.  An infant with asymptomatic hepatic granuloma probably caused by bacillus Calmette-Guérin (BCG) vaccination found incidentally at autopsy: a case report.

Authors:  Yutaka Tajima; Rie Takagi; Tamiko Nakajima; Yoshihiko Kominato
Journal:  Cases J       Date:  2008-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.